24 related articles for article (PubMed ID: 9638489)
1. Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells.
Ogasawara H; Noguchi M
Cells; 2021 Oct; 10(11):. PubMed ID: 34831128
[TBL] [Abstract][Full Text] [Related]
2. IBS-Symptoms in IBD Patients-Manifestation of Concomitant or Different Entities.
Szałwińska P; Włodarczyk J; Spinelli A; Fichna J; Włodarczyk M
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33374388
[TBL] [Abstract][Full Text] [Related]
3. IBS and IBD - separate entities or on a spectrum?
Spiller R; Major G
Nat Rev Gastroenterol Hepatol; 2016 Sep; 13(10):613-21. PubMed ID: 27667579
[TBL] [Abstract][Full Text] [Related]
4. 5-HT3 receptors promote colonic inflammation via activation of substance P/neurokinin-1 receptors in dextran sulphate sodium-induced murine colitis.
Utsumi D; Matsumoto K; Amagase K; Horie S; Kato S
Br J Pharmacol; 2016 Jun; 173(11):1835-49. PubMed ID: 26990520
[TBL] [Abstract][Full Text] [Related]
5. Substance P enhances neuronal area and epithelial cell proliferation after colon denervation in rats.
Buttow NC; Zucoloto S; Espreafico EM; Gama P; Alvares EP
Dig Dis Sci; 2003 Oct; 48(10):2069-76. PubMed ID: 14627357
[TBL] [Abstract][Full Text] [Related]
6. Changes in chemical coding of myenteric neurones in ulcerative colitis.
Neunlist M; Aubert P; Toquet C; Oreshkova T; Barouk J; Lehur PA; Schemann M; Galmiche JP
Gut; 2003 Jan; 52(1):84-90. PubMed ID: 12477766
[TBL] [Abstract][Full Text] [Related]
7. A novel tachykinin NK2 receptor antagonist prevents motility-stimulating effects of neurokinin A in small intestine.
Lördal M; Navalesi G; Theodorsson E; Maggi CA; Hellström PM
Br J Pharmacol; 2001 Sep; 134(1):215-23. PubMed ID: 11522614
[TBL] [Abstract][Full Text] [Related]
8. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
9. Substance P containing nerve fibers in ulcerative colitis.
Watanabe T; Kubota Y; Muto T
Int J Colorectal Dis; 1998; 13(2):61-7. PubMed ID: 9638489
[TBL] [Abstract][Full Text] [Related]
10. Substance P containing nerve fibers in rectal mucosa of ulcerative colitis.
Watanabe T; Kubota Y; Muto T
Dis Colon Rectum; 1997 Jun; 40(6):718-25. PubMed ID: 9194468
[TBL] [Abstract][Full Text] [Related]
11. Changes in neuropeptide-containing nerves in human colonic mucosa with inflammatory bowel disease.
Kimura M; Masuda T; Hiwatashi N; Toyota T; Nagura H
Pathol Int; 1994 Aug; 44(8):624-34. PubMed ID: 7524953
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptides and nerve growth in inflammatory bowel diseases: a quantitative immunohistochemical study.
Lee CM; Kumar RK; Lubowski DZ; Burcher E
Dig Dis Sci; 2002 Mar; 47(3):495-502. PubMed ID: 11913410
[TBL] [Abstract][Full Text] [Related]
13. [Changes in the number of neuroprotective transmitter containing mucosal nerve fibres in children with ulcerative colitis].
Kamińska B; Landowski P; Gonkowski S; Majewski M; Renke J; Korzon M
Med Wieku Rozwoj; 2006; 10(2):483-91. PubMed ID: 16825719
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
